Rapid Micro Biosystems stock: PDA event spotlights Rapid Micro Biosystems stock on October 26

Published on 10/24/2026 at 04:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Roth/MKM set a USD 3.00 target for Rapid Micro Biosystems stock on September 29, 2026. Q2 revenue was USD 8.05 million, up 11.00 percent.

Business update and valuation

Rapid Micro Biosystems will sponsor a pharmaceutical microbiology conference from October 26 to October 28, 2026.
Second-quarter revenue reached USD 8.05 million, up 11.00 percent year over year.
Roth/MKM set a USD 3.00 price target on September 29, 2026.
Rapid Micro Biosystems stock was last at USD 0.78 on October 23, 2026, with a USD 35.6 million market capitalization.

RPID, US75340L1044, Illustration mit AI erstellt.

Rapid Micro Biosystems (ISIN US75340L1044) is sponsoring the PDA Pharmaceutical Microbiology Conference from October 26 to October 28, 2026. According to the Rapid Micro Biosystems investor-relations page, the event will bring pharmaceutical microbiology professionals, quality leaders and regulatory experts together in Washington, D.C.

Revenue growth supports the case

Rapid Micro Biosystems reported USD 8.05 million in second-quarter 2026 revenue, an 11.00 percent increase from the prior-year period. The figure exceeded the USD 7.85 million analyst consensus, while net loss was USD 12.92 million for the quarter, according to Investing.com.

Gross margin reached 15.00 percent in the second quarter, compared with 5.00 percent in the first quarter. Operating cash flow was negative USD 12.70 million in the second quarter, making margin expansion and cash use central measures for the company.

Three dated signals shape RPID

On August 7, 2026, Rapid Micro Biosystems reported second-quarter revenue of USD 8.05 million. On September 29, 2026, Roth/MKM initiated coverage with a USD 3.00 price target, as Investing.com reported. On October 20, 2026, the company announced its sponsorship of the PDA conference.

What does the conference mean for sales?

The event gives the Growth Direct platform a customer-facing setting while Rapid Micro Biosystems had 169 validated systems at the end of the second quarter. Recurring revenue exceeded 60 percent of sales, according to Investing.com, giving the conference a direct connection to consumables and service growth.

Next event arrives October 26

The next dated company event is the PDA Pharmaceutical Microbiology Conference, scheduled for October 26 to October 28, 2026. A presentation will examine computer vision and artificial intelligence for early mold detection on the Growth Direct system.

Stock valuation remains speculative

Rapid Micro Biosystems stock was last at USD 0.78 on Nasdaq on October 23, 2026 at 4:00 p.m. ET. The same market snapshot places the company at a USD 35.6 million market capitalization, with a 52-week range of USD 0.76 to USD 4.94.